Log in or Sign up for Free to view tailored content for your specialty!
Endocrinology News
Wegovy improves functional class in patients with obesity, heart failure at 1 year
In patients with obesity-driven heart failure with preserved ejection fraction, semaglutide 2.4 mg was associated with more improvement in NYHA functional class compared with placebo, according to new data from the STEP-HFpEF trials.
Excessive gestational weight gain common among military health beneficiaries
Gestational weight gain that exceeded National Academy of Medicine guidelines occurred among 75% of pregnant women who were TRICARE beneficiaries and gave birth in 2018 or 2019, according to findings published in Obesity.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: Petition asks FDA to revise fenofibrate labeling to emphasize no CV outcome benefits
Because the science underpinning medicine evolves so quickly, it is not uncommon for some doctors to manage patients based on old evidence that is no longer a best practice; this is called clinical inertia.
Hypercortisolism prevalent among 24% of adults with difficult-to-control type 2 diabetes
ORLANDO — Nearly one-quarter of adults with difficult-to-control type 2 diabetes also have hypercortisolism, and treating hypercortisolism may also benefit glycemic control in those with both conditions, according to speakers.
FLOW: Semaglutide cuts kidney, cardiovascular, death risks regardless of SGLT2 use
ORLANDO — Semaglutide use was associated with significant reductions in worsening of kidney disease, cardiovascular events and all-cause death vs. placebo for adults with type 2 diabetes regardless of concomitant use of SGLT2 inhibitors.
First generic GLP-1 receptor agonist launched
Teva Pharmaceuticals announced it has launched the first generic version of a GLP-1 receptor agonist in the United States, liraglutide 1.8 mg.
Q&A: International consensus provides guidance for monitoring early-stage type 1 diabetes
ORLANDO — An international consensus group has offered the first guidance for clinicians about how to monitor people who test positive for islet autoantibodies, indicating high risk for developing type 1 diabetes.
Insulin adjustments suggested by mobile app cut HbA1c for adults with type 1 diabetes
ORLANDO — Adults with type 1 diabetes had larger reductions in HbA1c using a mobile app that made recommended adjustments to insulin therapy than users who did not receive weekly adjustments, according to a speaker.
Sex differences in weight loss, not health with semaglutide in heart failure with obesity
ORLANDO — Among adults with obesity-related heart failure with preserved ejection fraction, women taking semaglutide lost significantly more weight than men, but greater weight loss did not result in extra health benefits for women vs. men.
Building wealth: Take these initial steps post-training
The concept of delayed gratification has been ingrained in us throughout medical school and residency. This mentality can sometimes lead to explosive spending as an attending when one enjoys a significant salary boost.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read